Chemoinformaics analysis of HEXAHYDROXYDIPHENIC-ACID
| Molecular Weight | 292.284 | nRot | 10 |
| Heavy Atom Molecular Weight | 272.124 | nRig | 2 |
| Exact Molecular Weight | 292.116 | nRing | 0 |
| Solubility: LogS | -0.051 | nHRing | 0 |
| Solubility: LogP | 0.22 | No. of Aliphatic Rings | 0 |
| Acid Count | 4 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 39.7919 |
| nHD | 4 | BPOL | 23.5361 |
| QED | 0.56 |
| Synth | 1.594 |
| Natural Product Likeliness | 0.456 |
| NR-PPAR-gamma | 0.793 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.166 |
| CACO-2 | -5.866 |
| MDCK | 0.000738284 |
| BBB | 0.125 |
| PPB | 0.561349 |
| VDSS | 0.254 |
| FU | 0.484631 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.05 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.006 |
| CL | 3.928 |
| T12 | 0.87 |
| hERG | 0.004 |
| Ames | 0.014 |
| ROA | 0.006 |
| SkinSen | 0.122 |
| Carcinogencity | 0.071 |
| EI | 0.982 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.545592 |